Healthcare Distribution Alliance – Patients Move Us.

+ About
- Role of Distributors
- Membership
- HDA History
- Member Directory
- Staff Directory
- Industry Recognition
- Executive Committee
- Mission and Values
- Board of Directors
- Join HDA
- Councils and Committees
- Careers
- About
  
  Information regarding HDA's history, leadership, mission, values and staff.
+ Issues
- COVID-19 Response
- Reimbursement
- Pharmaceutical Traceability
- Distributor Licensure
- Importation of Prescription Medicines
- Drug Shortages
- Prescription Drug Abuse and Diversion
- Emergency Preparedness
- Taxes
- Grassroots Advocacy
- Issues
  
  HDA reviews key priority issues and advocates on behalf of its pharmaceutical distributor members for standards, public policies and business processes that ensure a safe and efficient supply chain.
+ Events
- Distribution Management Webinar Series
- Traceability Seminar
- Distribution Management Conference and Expo
- PCSC Educational Seminar
- BLC Online
- Webinars
- Annual Board and Membership Meeting
- Speaker Resource Center
- Events
  
  HDA regularly brings members and key healthcare supply chain stakeholders together to share industry information, learn about best practices, and be introduced to new products and services.
+ News
- Press Releases
- Blog
- Testimony
- HDA in the News
  
  Press releases, public testimony executive statements and information on HDA's efforts on behalf of pharmaceutical distributors and the supply chain.
+ Resources
- Publications
- COVID-19 Response
- Health Delivered
- Professional Development
- Webinars
- PCSC
- Allied Against Opioid Abuse
- Annual Report
- Resources
  
  HDA and the HDA Research Foundation produce a variety of resources to enhance the value of the supply chain and increase industry knowledge.

Share Print

Home | Resources |

Publications

The Risks and Realities of Commercial Drug Importation

Electronic Download

PUBLISHED 2019

This report explores proposed drug importation policy — in general, and with an emphasis on federal legislation proposed since 2013.

Based on expert interviews, literature reviews and quantitative data modeling, the report analyzes policies for their commercial feasibility, operational costs to the supply chain and overall effects on patient safety.

Publication Sponsors

Platinum: Anda, Inc.; Novartis Pharmaceuticals Corporation

Gold: Astellas Pharma US, Inc.; Pfizer Inc.

Silver: Genentech, A Member of the Roche Group

Download

SHOPPING CART (0)

ITEMS IN CART: 0

TOTAL: $ 0

Checkout VIEW CART

Privacy | Antitrust | Sitemap | Terms of Use | Contact

Website design and development by Americaneagle.com, inc

HDA: E | C | C2 | NF | O365